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Background
Protein damage induced by retained uremic solutes may
be an important component in the pathophysiology of
advanced renal disease. Albumin isolated from hemodia-
lysis patients was recently shown to block high-density
lipoprotein (HDL) receptor-mediated cholesterol uptake.
However, post-translational modifications that render
albumin a scavenger receptor class B type I (SR-BI)
ligand are not known. We hypothesized that the elimina-
tion of positive charge through oxidation of albumin-
lysine residues is required to generate recognition motifs
for SR-BI. Since carbamylation and carboxymethylation
are major lysine modifications in vivo, we aimed at inves-
tigating their influence on the binding properties of HD-
albumin to SR-BI.
Methods
Albumin from HD patients and control subjects was iso-
lated from serum by affinity chromatography. Mass spec-
trometry was used to study structurally defined lysine
modifications on HD-albumin. Competition experiments
(displacement of Alexa-labeled HDL) were performed to
assess binding affinity of modified albumin to SR-BI.
Results
We identified a significant increase in 3-chlorotyrosine,
carbamyllysine and carboxymethyllysine content on HD-
albumin. Competition experiments revealed that chloroly-
sine and carbamyllysine mediate binding of AOPP-albumin
to SR-BI whereas binding properties of carboxmethyllysine
did not differ significantly from native albumin.
Conclusions
Oxidation and carbamylation of serum albumin generate
relevant SR-BI antagonists in renal disease that may inter-
fere with SR-BI-mediated reverse cholesterol transport.
Displacement of HDL from its major receptor may result
in decreased hepatic cholesterol uptake, depressed HDL
metabolism and abnormal HDL composition and function.
Dysfunctional reverse cholesterol transfer may contribute
to the excessive cardiovascular mortality observed in
patients suffering from renal disease.
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